SB, N., B, A., JD, A., R, W., S, K., & ZA, K. (2023). Letter to the editor on use of antibodies from convalescent sera in the treatment of moderate and severe Covid-19 infection. Antiviral therapy, 28(3), 13596535231186866. https://doi.org/10.1177/13596535231186866
Chicago Style (17th ed.) CitationSB, Nahhal, Awada B, Azzo JD, Wazzi-Mkahal R, Kanj S, and Kanafani ZA. "Letter to the Editor on Use of Antibodies from Convalescent Sera in the Treatment of Moderate and Severe Covid-19 Infection." Antiviral Therapy 28, no. 3 (2023): 13596535231186866. https://doi.org/10.1177/13596535231186866.
MLA (9th ed.) CitationSB, Nahhal, et al. "Letter to the Editor on Use of Antibodies from Convalescent Sera in the Treatment of Moderate and Severe Covid-19 Infection." Antiviral Therapy, vol. 28, no. 3, 2023, p. 13596535231186866, https://doi.org/10.1177/13596535231186866.